Foresee Pharmaceuticals financials at a glance

+ Portfolio

The revenue of Foresee Pharmaceuticals is reported as 0.19504 billion New Dollars in the fiscal year 2023. The earnings were -8.14 New Dollars per share in 2023, which was 103.5 lower than 2022. And about -0.73528 billion New Dollars are reported as free cash flow in the financials of Foresee Pharmaceuticals 2023. No dividends were paid to the shareholders of the Foresee Pharmaceuticals stock TPEX:6576 in the financial year 2023.

NT$195.04M

Revenue

NT$-8.14

Earnings Per Share

58.44%

Gross Margin %

NT$-,406.00M

Free Cash Flow

Revenue

195.04

Earnings Per Share

-8.14

Gross Margin %

58.44

Free Cash Flow

-,406.00

Financials

Year	Year	TTM	2023	2022	2021	2020	2019	2018
Rev.	Revenue	N/A	NT$195.04M	NT$301.51M	NT$226.03M	NT$230.44M	NT$75.20M	NT$26.04M
GM %	Gross Margin %	62.17%	58.44%	91.53%	77.46%	75.26%	77.06%	46.37%
OM	Operating Margin	0.00%	0.00%	-,155.70%	-,238.30%	-,210.38%	0.00%	0.00%
EPS	Earnings Per Share	NT$-7.37	NT$-8.14	NT$-4.00	NT$-4.85	NT$-5.04	NT$-5.08	NT$-6.55
Div.	Dividends	N/A	NT$0.00	NT$0.00	NT$0.00	NT$0.00	NT$0.00	NT$0.00
PR %	Payout Ratio %	0	0	0	0	0	0	0
Sha.	Shares	N/AM	135.82M	118.17M	117.94M	116.94M	100.33M	88.23M
OCF	Operating Cash Flow	N/A	NT$-,689.00M	NT$-,233.22M	NT$-,213.33M	NT$-,674.80M	NT$-,447.82M	NT$-,462.43M
FCF	Free Cash Flow	N/A	NT$-,406.00M	NT$-,283.32M	NT$-,220.19M	NT$-,687.58M	NT$-,534.34M	NT$-,476.53M
FCFS	Free Cash Flow Per Share	NT$-6.96	NT$-7.34	NT$-2.47	NT$-1.88	NT$-6.93	NT$-6.46	NT$-6.79

Foresee Pharmaceuticals financials at a glance

Financials

Discover